Real-world evidence is being utilized to drive innovation in the biopharma industry. The use of real-world data is expected to power next-generation biopharma and lead to breakthroughs, with potential applications in drug development and healthcare solutions. The integration of this data with technologies such as artificial intelligence is also being explored, with potential economic and ethical implications.